At a glance

Most Recent Events

30 May 2014
New trial record

12 May 2014
Data from the phase I/II adult repeat-dose studies completed by Ultragenyx's collaborative partner Kyowa Hakko Kirin Co., Ltd. are expected to be released at scientific conferences in 2014.

Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

Login
with a username/password associated to an account with a valid subscription